THERESE SCHRANDT: Open Payments
NPI 1679555221 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,166 in 177 payments from 17 companies in 2025. Trend: 2023 $2,485 · 2024 $3,277 · 2025 $3,166
Food & beverage: $3,076Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $606 |
| Janssen Biotech, Inc. | 26 | $570 |
| E.R. Squibb & Sons, L.L.C. | 16 | $430 |
| Lilly USA, LLC | 14 | $193 |
| GENZYME CORPORATION | 8 | $185 |
| Galderma Laboratories, L.P. | 13 | $178 |
| Novartis Pharmaceuticals Corporation | 12 | $177 |
| UCB, Inc. | 12 | $167 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $167 |
| Amgen Inc. | 11 | $137 |
Products named: TREMFYA, Sotyktu, SKYRIZI, RINVOQ, DUPIXENT, TALTZ, Bimzelx, COSENTYX.
Industry payments across KS — which companies pay providers there.
